| Completed | Alisertib and Fractionated Stereotactic Radiosurgery in Treating Patients With Recurrent High Grade Gliomas NCT02186509 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Phase 1 |
| Completed | Genetically Modified Neural Stem Cells, Flucytosine, and Leucovorin for Treating Patients With Recurrent High- NCT02015819 | City of Hope Medical Center | Phase 1 |
| Withdrawn | Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors NCT02194452 | Sue O'Dorisio | N/A |
| Completed | Bevacizumab With or Without Anti-Endoglin Monoclonal Antibody TRC105 in Treating Patients With Recurrent Gliob NCT01648348 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Completed | Carboplatin in Treating Patients With Recurrent High-Grade Gliomas NCT01644955 | James Elder | Phase 1 |
| Terminated | High-Dose Vorinostat and Fractionated Stereotactic Body Radiation Therapy in Treating Patients With Recurrent NCT01378481 | National Cancer Institute (NCI) | Phase 1 |
| Terminated | 3T MRI Biomarkers of Glioma Treatment Response NCT01996527 | Vanderbilt-Ingram Cancer Center | EARLY_Phase 1 |
| Terminated | Efficacy of Hypofractionated XRT w/Bev. + Temozolomide for Recurrent Gliomas NCT01478321 | Northwestern University | Phase 2 |
| Terminated | Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients Wi NCT02967380 | University of Southern California | N/A |
| Completed | Bafetinib in Treating Patients With Recurrent High-Grade Glioma or Brain Metastases NCT01234740 | City of Hope Medical Center | Phase 1 |
| Terminated | Yoga Therapy in Treating Patients With Malignant Brain Tumors NCT01234805 | Wake Forest University Health Sciences | N/A |
| Terminated | RO4929097and Bevacizumab in Treating Patients With Progressive or Recurrent Malignant Glioma NCT01189240 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Completed | A Pilot Feasibility Study of Oral 5-Fluorocytosine and Genetically-Modified Neural Stem Cells Expressing E.Col NCT01172964 | City of Hope Medical Center | Phase 1 |
| Completed | Fluorine F 18 Fluorodopa-Labeled PET Scan in Planning Surgery and Radiation Therapy in Treating Patients With NCT01165632 | Mayo Clinic | EARLY_Phase 1 |
| Terminated | Aminolevulinic Acid During Surgery in Treating Patients With Malignant Brain Tumors NCT01148966 | University of Washington | Phase 1 |
| Terminated | Erlotinib Hydrochloride and Isotretinoin in Treating Patients With Recurrent Malignant Glioma NCT01103375 | Wake Forest University Health Sciences | Phase 1 |
| Completed | RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma NCT01119599 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors NCT01131234 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Temsirolimus and Perifosine in Treating Patients With Recurrent or Progressive Malignant Glioma NCT01051557 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Completed | Bendamustine Hydrochloride in Treating Patients With Recurrent or Progressive Anaplastic Glioma NCT00823797 | University of Washington | Phase 2 |
| Completed | Aflibercept, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Gliobl NCT00650923 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Sunitinib in Treating Patients With Recurrent Malignant Gliomas NCT00499473 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Pri NCT00492089 | National Cancer Institute (NCI) | Phase 2 |
| Completed | VEGF Trap in Treating Patients With Recurrent Malignant Gliomas That Did Not Respond to Temozolomide NCT00369590 | National Cancer Institute (NCI) | Phase 2 |
| Active Not Recruiting | Vorinostat and Temozolomide in Treating Patients With Malignant Gliomas NCT00268385 | National Cancer Institute (NCI) | Phase 1 |
| Terminated | Positron Emission Tomography Using Fluorine F 18 EF5 to Find Oxygen in Tumor Cells of Patients Who Are Undergo NCT00110032 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant Glioma NCT00112736 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Completed | FR901228 in Treating Patients With Recurrent High-Grade Gliomas NCT00085540 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Completed | Sorafenib in Treating Patients With Recurrent or Progressive Malignant Glioma NCT00093613 | National Cancer Institute (NCI) | Phase 1 |
| Completed | A Phase I/II Trial of BMS-247550 for Treatment of Patients With Recurrent High-Grade Gliomas NCT00045708 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Completed | Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive Meningioma NCT00045110 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Completed | Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction NCT00030498 | National Cancer Institute (NCI) | Phase 1 |
| Terminated | Use of EF5 to Measure the Oxygen Level in Tumor Cells of Patients Undergoing Surgery or Biopsy for Newly Diagn NCT00430079 | National Cancer Institute (NCI) | N/A |
| Terminated | Bortezomib in Treating Patients With Recurrent Glioma NCT00006773 | National Cancer Institute (NCI) | Phase 1 |
| Withdrawn | Genetically Modified Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gl NCT02055196 | City of Hope Medical Center | Phase 1 |